International Assets Investment Management LLC Sells 100,000 Shares of The Clorox Company $CLX

International Assets Investment Management LLC decreased its stake in The Clorox Company (NYSE:CLX) by 96.9% in the third quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 3,154 shares of the company’s stock after selling 100,000 shares during the quarter. International Assets Investment Management LLC’s holdings in Clorox were worth $390,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors also recently bought and sold shares of the stock. Nomura Asset Management Co. Ltd. lifted its stake in Clorox by 9.0% in the second quarter. Nomura Asset Management Co. Ltd. now owns 335,514 shares of the company’s stock worth $40,285,000 after purchasing an additional 27,639 shares during the last quarter. Simplicity Wealth LLC grew its stake in shares of Clorox by 157.3% during the second quarter. Simplicity Wealth LLC now owns 18,316 shares of the company’s stock valued at $2,199,000 after buying an additional 11,198 shares during the last quarter. Hudson Bay Capital Management LP purchased a new stake in shares of Clorox in the second quarter worth approximately $8,568,000. Vise Technologies Inc. bought a new stake in shares of Clorox during the 2nd quarter worth approximately $328,000. Finally, Brookstone Capital Management lifted its stake in shares of Clorox by 1,395.4% during the 3rd quarter. Brookstone Capital Management now owns 94,332 shares of the company’s stock worth $11,631,000 after acquiring an additional 88,024 shares during the last quarter. Hedge funds and other institutional investors own 78.53% of the company’s stock.

Insiders Place Their Bets

In related news, Director Pierre R. Breber bought 4,000 shares of the company’s stock in a transaction on Friday, November 21st. The shares were acquired at an average price of $104.13 per share, with a total value of $416,520.00. Following the transaction, the director owned 13,000 shares of the company’s stock, valued at $1,353,690. The trade was a 44.44% increase in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. 0.63% of the stock is currently owned by corporate insiders.

Key Clorox News

Here are the key news stories impacting Clorox this week:

• Positive Sentiment: Clorox agreed to acquire GOJO Industries, the maker of Purell, for $2.25 billion in cash — a strategic push deeper into skin health and hygiene that management says is growth‑accretive and advances its IGNITE plan. The deal expands Clorox’s consumer and professional hygiene footprint and is the primary catalyst for today’s stock strength. Clorox Announces Acquisition of GOJO
• Positive Sentiment: Management updated FY‑2026 EPS guidance to $5.95–$6.30, slightly above consensus, and reiterated revenue targets — a sign the company expects the combined portfolio and cost initiatives to help stabilize growth. This guidance helped reassure investors even as organic revenue pressures persist. (Company guidance release)
• Neutral Sentiment: Deutsche Bank raised its price target on CLX to $114 (keeps a Hold rating), a small incremental positive that signals modest upside in analysts’ view but not a strong buy signal. Deutsche Bank Raises Price Target
• Neutral Sentiment: Broad media and analyst coverage (WSJ, CNBC, MarketWatch) has amplified the deal’s reach and provided investors with deal details and management commentary — increasing attention but not resolving long‑term execution questions. WSJ: Clorox to Buy Purell-Maker
• Negative Sentiment: Some sell‑side skepticism remains: Barclays kept an Underweight (sell) stance despite a small target tweak, and commentary from critics highlights valuation and fundamental concerns that could limit upside until integration is proven. Barclays Remains a Sell
• Negative Sentiment: The deal is being financed with debt, increasing leverage and short‑term balance‑sheet risk; investors will watch integration execution and cost synergy realization closely — these risks are why some analysts remain cautious. WSJ: Deal Financed with Debt
• Negative Sentiment: Critical commentary (e.g., Seeking Alpha) questions whether the acquisition meaningfully fixes Clorox’s underlying growth challenges and suggests the company still needs stronger organic execution — a narrative that could cap the stock if results don’t improve. Seeking Alpha: Adding Sanitizers, But In Need Of Getting Its Hands Dirty

Analyst Upgrades and Downgrades

Several brokerages have commented on CLX. Rothschild & Co Redburn cut their price objective on Clorox from $120.00 to $115.00 and set a “neutral” rating on the stock in a research report on Wednesday, November 5th. Barclays reissued an “underweight” rating and set a $109.00 target price on shares of Clorox in a research note on Friday, January 16th. TD Cowen reaffirmed a “hold” rating on shares of Clorox in a research note on Thursday, January 8th. JPMorgan Chase & Co. decreased their price objective on shares of Clorox from $120.00 to $114.00 and set a “neutral” rating for the company in a report on Friday, January 16th. Finally, Zacks Research raised shares of Clorox from a “strong sell” rating to a “hold” rating in a research report on Wednesday, November 26th. One analyst has rated the stock with a Buy rating, thirteen have issued a Hold rating and four have issued a Sell rating to the stock. Based on data from MarketBeat, the company presently has an average rating of “Reduce” and an average price target of $122.19.

Clorox Stock Performance

CLX stock opened at $113.46 on Friday. The Clorox Company has a 1-year low of $96.66 and a 1-year high of $164.22. The business has a 50-day moving average price of $103.80 and a 200 day moving average price of $114.78. The company has a market capitalization of $13.84 billion, a P/E ratio of 17.81, a PEG ratio of 0.57 and a beta of 0.58. The company has a debt-to-equity ratio of 18.01, a current ratio of 0.76 and a quick ratio of 0.50.

Clorox (NYSE:CLX) last posted its earnings results on Monday, November 3rd. The company reported $0.85 EPS for the quarter, beating analysts’ consensus estimates of $0.78 by $0.07. Clorox had a net margin of 11.68% and a return on equity of 358.39%. The business had revenue of $1.43 billion for the quarter, compared to the consensus estimate of $1.41 billion. During the same quarter last year, the firm posted $1.86 EPS. The company’s revenue for the quarter was down 18.9% on a year-over-year basis. Clorox has set its FY 2026 guidance at 5.950-6.300 EPS. As a group, equities research analysts forecast that The Clorox Company will post 7.15 EPS for the current fiscal year.

Clorox Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, February 13th. Investors of record on Wednesday, January 28th will be paid a $1.24 dividend. The ex-dividend date of this dividend is Wednesday, January 28th. This represents a $4.96 dividend on an annualized basis and a yield of 4.4%. Clorox’s payout ratio is 77.86%.

Clorox Profile

The Clorox Company is a leading manufacturer and marketer of consumer and professional products designed to help people care for their homes and live healthy, sustainable lives. Its portfolio spans cleaning and household products, food and beverages, water filtration systems and cat litter, serving both retail and institutional customers. The company’s flagship bleach and disinfecting products are well known in the United States and many international markets, where they help prevent the spread of germs in homes, hospitals, schools and businesses.

Clorox’s diverse brand lineup includes liquid bleach and surface cleaners, eco-friendly cleaning tools, food preservation and preparation items, charcoal grills and briquettes, specialty foods and beverages, pet care products and personal care lines.